dicetylphosphate has been researched along with tetraethylenepentamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, T; Dewa, T; Hatanaka, K; Kenjo, E; Kikuchi, H; Koide, H; Maeda, N; Matsushita, S; Nango, M; Oku, N; Tsuzuku, T; Yonenaga, N | 1 |
| Asai, T; Dewa, T; Kenjo, E; Nango, M; Oku, N; Shimizu, K; Tsuruta, A; Yonenaga, N | 1 |
| Ando, H; Asai, T; Dewa, T; Hatanaka, K; Ishii, T; Kenjo, E; Nango, M; Oku, N; Shimizu, K; Tsukada, H; Urita, Y; Yonenaga, N | 1 |
3 other study(ies) available for dicetylphosphate and tetraethylenepentamine
| Article | Year |
|---|---|
Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery.
Topics: Animals; Base Sequence; Cell Line, Tumor; Cholesterol; Ethylenediamines; Fibrosarcoma; Gene Silencing; Humans; Injections, Intravenous; Liposomes; Male; Mice; Mice, Inbred BALB C; Molecular Imaging; Organophosphates; Polyethylene Glycols; RNA, Small Interfering; Spectrophotometry, Infrared | 2011 |
RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
Topics: Animals; Cations; Cell Line, Tumor; Drug Carriers; Ethylenediamines; Genetic Therapy; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Organophosphates; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2012 |
Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy.
Topics: Animals; Cell Proliferation; Ethylenediamines; Liposomes; Lung; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organophosphates; Peptides, Cyclic; Polyethylene Glycols; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Salivary alpha-Amylases; Vascular Endothelial Growth Factor A | 2013 |